Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania RH Rhode Island South Carolina South Dakota Tennessee Texas Uncategorized Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 2603 blog entries.

Colorado

NACDS testified in support of HB26-1336, a bill designed to expand access to pharmacy healthcare services for both Medicaid and commercial patients, at a House Health and Human Services Committee hearing on March 31. The bill was amended to allow children 5 years of age and older to receive test-and-treat services directly from pharmacies. Additionally, it permits pharmacy technicians, under pharmacist supervision, to perform final product verification and other technical, non-discretionary tasks.

Also in Colorado, SB26-032, a bill designed to expand access to pharmacy vaccine services by increasing pharmacists' authority to prescribe and administer vaccines and by providing liability protections for pharmacists, was signed into law by Gov. Jared Polis (D) on March 27. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2026-04-03T09:38:38-04:00April 3, 2026|Colorado|

Florida

Gov. Ron DeSantis (R) signed HB 697, which will take effect July 1. The legislation includes provisions related to the Ryan White Part B AIDS Drug Assistance Program (ADAP), providing bridge funding to maintain the program without changes through June 30. The law also prohibits PBMs from restricting a pharmacy or pharmacist from declining to dispense a drug when the reimbursement rate is below the actual acquisition cost. Additionally, it bars PBMs from reimbursing a pharmacy or pharmacist at a lower rate than they reimburse an affiliated pharmacy or pharmacist. Finally, the law states that the administrative appeal procedure must allow a pharmacy or pharmacist the option to submit a consolidated administrative appeal representing multiple adjudicated claims that share the same drug and day supply and have a date of service occurring within the same calendar month.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2026-04-03T09:37:53-04:00April 3, 2026|Florida|

Illinois

The Department of Healthcare and Family Services (HFS) Bureau of Professional and Ancillary Services (BPAS) occasionally receives requests from clinicians in the provider community for individual drug reviews. To ensure requests for reviews are fair, balanced and relevant to the Medicaid Preferred Drug List (PDL), the BPAS has established procedures for handling these requests. After the BPAS receives the request for a drug review, the BPAS pharmacy staff establish the appropriateness of the request. The review takes place over a three-month period, beginning from the date the drug review is requested. Reviews are evaluated both clinically and financially. A recommendation may be presented to the Drugs & Therapeutics (D&T) Advisory Board at the earliest opportunity. 

Complete Drug Review Request 

Preferred Drug List, effective April 1  

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2026-04-03T09:36:38-04:00April 3, 2026|Illinois|

Kansas

NACDS sent Gov. Laura Kelly (D) a letter urging her to sign the Consumer Prescription Protection and Accountability Act. SB 20, formerly SB 360, is a comprehensive PBM reform bill that clarifies auditing procedures, specifies reporting requirements and strengthens enforcement authority by enabling both compliance and financial examinations.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2026-04-03T09:36:00-04:00April 3, 2026|Kansas|

Missouri

SB 878, was amended and passed the Senate on March 23. The bill expands pharmacists’ scope authority for CLIA-waived tests and allows prescribing certain types of medical equipment. It also enhances the Board of Pharmacy’s authority to allow pharmacies to dispense medications during a declared emergency. In addition, it would allow the over-the-counter sale of ivermectin and hydroxychloroquine, with a warning label, once the FDA authorizes them for over-the-counter dispensing. The bill was sent to the House of Representatives for further action.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2026-04-03T09:35:23-04:00April 3, 2026|Missouri|

Nebraska

The Department of Health and Human Services announced a public hearing to receive comments on proposed changes to Title 471, Chapter 7​  of the Nebraska Administrative Code (NAC) – Durable Medical Equipment, Prosthetics, Orthotics, and Medical Supplies (DMEPOS).  

Authority for these regulations is found in Neb. Rev. Stat. § 81-3117(7) and § 68-908. 

Interested persons may attend the hearing and provide verbal or written comments, or mail, fax or email written comments, no later than the day of the hearing to: DHHS Legal Services, PO Box 95026, Lincoln, NE 68509-5026, (402) 742-2382 (fax) or dhhs.regulations@nebraska.gov, respectively. 

A copy of the proposed changes is available online at http://www.sos.ne.gov, or by contacting DHHS at the mailing address or email above, or by phone at (402) 471-8417. The fiscal impact statement for these proposed changes may be obtained at the office of the Secretary of State, Regulations Division, 1201 N Street, Suite 120, Lincoln, NE 68508, or by calling (402) 471-2385. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2026-04-03T09:34:41-04:00April 3, 2026|Nebraska|

Ohio

Gov. Mike Dewine (R) signed HB 229, sponsored by Rep. Kelli Deeter (R), into law this week. The law establishes licensure for PBMs beginning in 2027; prohibits certain PBM practices; and allows the Department of Insurance to take disciplinary actions for violations, including fines and license suspension or revocation. Additionally, it requires PBMs to enter into written agreements and provide regular accounting of rebates, fees and other financial arrangements to plan sponsors and permits the Department to access PBM records and data. 

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2026-04-03T09:33:59-04:00April 3, 2026|Ohio|

Oklahoma

On March 26, the Senate passed SB 2074 by a decisive 34-3 vote. This bill aims to establish a reimbursement rate floor of NADAC plus a dispensing fee that cannot be lower than the Medicaid fee-for-service rate. The legislation was reported to the House for further consideration.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2026-04-03T09:33:09-04:00April 3, 2026|Oklahoma|
Go to Top